Stereotactic ablative radiotherapy for primary kidney cancer – An international patterns of practice survey
SABR is a relatively newer indication for primary RCC, offered by less than 50% of respondents, with both consistent and variable practice patterns observed.
Authors
- Anand Swaminath (ORCID: https://orcid.org/0000-0003-4013-1980)
- Samantha Sigurdson (ORCID: https://orcid.org/0000-0002-8722-6111)
- Raquibul Hannan (ORCID: https://orcid.org/0000-0003-1282-056X)
- Matthias Gückenberger (ORCID: https://orcid.org/0000-0002-7146-9071)
- Scott Carlyle Morgan (ORCID: https://orcid.org/0000-0002-6568-3346)
- Simon S. Lo (ORCID: https://orcid.org/0000-0002-3744-4065)
- Muhammad Ali (ORCID: https://orcid.org/0000-0002-3285-9165)
- Katherine Taplin
Institutions
- University of Ottawa (CA)
- The University of Melbourne (AU)
- University of Washington (US)
- University of Zurich (CH)
- Juravinski Cancer Centre (CA)
- Peter MacCallum Cancer Centre (AU)
- Ottawa Hospital (CA)
- University Hospital of Zurich (CH)
- The University of Texas Southwestern Medical Center (US)
- McMaster University (CA)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1016/j.ctro.2024.100891
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42